Folgen
salim khakoo
salim khakoo
Bestätigte E-Mail-Adresse bei soton.ac.uk - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
DL Thomas, CL Thio, MP Martin, Y Qi, D Ge, C O’hUigin, J Kidd, K Kidd, ...
Nature 461 (7265), 798-801, 2009
26912009
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection
SI Khakoo, CL Thio, MP Martin, CR Brooks, X Gao, J Astemborski, ...
Science 305 (5685), 872-874, 2004
14542004
MAIT cells are activated during human viral infections
B Van Wilgenburg, I Scherwitzl, EC Hutchinson, T Leng, A Kurioka, ...
Nature communications 7 (1), 11653, 2016
4692016
HIV-1 adaptation to NK-cell-mediated immune pressure
G Alter, D Heckerman, A Schneidewind, L Fadda, CM Kadie, JM Carlson, ...
Nature 476 (7358), 96-100, 2011
4522011
KIR and disease: a model system or system of models?
SI Khakoo, M Carrington
Immunological reviews 214 (1), 186-201, 2006
3492006
Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans
SI Khakoo, R Rajalingam, BP Shum, K Weidenbach, L Flodin, DG Muir, ...
Immunity 12 (6), 687-698, 2000
3312000
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts
P Duggal, CL Thio, GL Wojcik, JJ Goedert, A Mangia, R Latanich, AY Kim, ...
Annals of internal medicine 158 (4), 235-245, 2013
2392013
Activation of natural killer cells during acute infection with hepatitis C virus
B Amadei, S Urbani, A Cazaly, P Fisicaro, A Zerbini, P Ahmed, G Missale, ...
Gastroenterology 138 (4), 1536-1545, 2010
2262010
Consistent beneficial effects of killer cell immunoglobulin‐like receptor 2DL3 and group 1 human leukocyte antigen‐C following exposure to hepatitis C virus
S Knapp, U Warshow, D Hegazy, L Brackenbury, IN Guha, A Fowell, ...
Hepatology 51 (4), 1168-1175, 2010
2052010
Peptide antagonism as a mechanism for NK cell activation
L Fadda, G Borhis, P Ahmed, K Cheent, SV Pageon, A Cazaly, ...
Proceedings of the National Academy of Sciences 107 (22), 10160-10165, 2010
1872010
Natural killer cells: integrating diversity with function
K Cheent, SI Khakoo
Immunology 126 (4), 449-457, 2009
1802009
Immunotherapy for hepatocellular carcinoma: current and future
MP Johnston, SI Khakoo
World journal of gastroenterology 25 (24), 2977, 2019
1692019
Ribavirin and interferon alfa‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions
S Khakoo, P Glue, L Grellier, B Wells, A Bell, C Dash, I Murray‐Lyon, ...
British journal of clinical pharmacology 46 (6), 563-570, 1998
1681998
The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation
M Luevano, M Daryouzeh, R Alnabhan, S Querol, S Khakoo, A Madrigal, ...
Human immunology 73 (3), 248-257, 2012
1582012
Hanging in the balance
AP Williams, AR Bateman, SI Khakoo
Molecular interventions 5 (4), 226, 2005
1522005
KIR/HLA interactions and pathogen immunity
KM Jamil, SI Khakoo
BioMed Research International 2011, 2011
1492011
Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience
SM Vidal, SI Khakoo, CA Biron
Current opinion in virology 1 (6), 497-512, 2011
1442011
Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses
S Pelletier, C Drouin, N Bédard, SI Khakoo, J Bruneau, NH Shoukry
Journal of hepatology 53 (5), 805-816, 2010
1392010
Histological assessment of the Sydney classification of endoscopic gastritis.
SI Khakoo, AJ Lobo, NA Shepherd, SP Wilkinson
Gut 35 (9), 1172-1175, 1994
1341994
Natural killer cells and hepatitis C: action and reaction
K Cheent, SI Khakoo
Gut 60 (2), 268-278, 2011
1272011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20